Point Of Care Diagnostics Market (By Product: Infectious Diseases, Glucose Testing, Cardiac Markers; By End-use: Clinics, Home, Hospitals) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Point Of Care Diagnostics Market 

5.1. COVID-19 Landscape: Point Of Care Diagnostics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Point Of Care Diagnostics Market, By Product

8.1. Point Of Care Diagnostics Market, by Product, 2022-2030

8.1.1. Glucose Testing

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Hb1Ac Testing

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Coagulation Testing

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Fertility/Pregnancy

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Infectious Disease

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Cardiac Markers

8.1.6.1. Market Revenue and Forecast (2017-2030)

8.1.7. Thyroid Stimulating Hormone

8.1.7.1. Market Revenue and Forecast (2017-2030)

8.1.8. Hematology

8.1.8.1. Market Revenue and Forecast (2017-2030)

8.1.9. Primary Care Systems

8.1.9.1. Market Revenue and Forecast (2017-2030)

8.1.10. Decentralized Clinical Chemistry

8.1.10.1. Market Revenue and Forecast (2017-2030)

8.1.11. Feces

8.1.11.1. Market Revenue and Forecast (2017-2030)

8.1.2. Lipid Testing

8.1.12.1. Market Revenue and Forecast (2017-2030)

8.1.13. Cancer Marker

8.1.13.1. Market Revenue and Forecast (2017-2030)

8.1.14. Blood Gas/Electrolytes

8.1.14.1. Market Revenue and Forecast (2017-2030)

8.1.15. Ambulatory Chemistry

8.1.15.1. Market Revenue and Forecast (2017-2030)

8.1.16. Drug of Abuse (DOA) Testing

8.1.16.1. Market Revenue and Forecast (2017-2030)

8.1.17. Urinalysis/Nephrology

8.1.17.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Point Of Care Diagnostics Market, By End-use

9.1. Point Of Care Diagnostics Market, by End-use, 2022-2030

9.1.1. Clinics

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Hospitals

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Home

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Assisted Living Healthcare Facilities

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Laboratory

9.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Point Of Care Diagnostics Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Product (2017-2030)

10.1.2. Market Revenue and Forecast, by End-use (2017-2030)

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Product (2017-2030)

10.1.3.2. Market Revenue and Forecast, by End-use (2017-2030)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Product (2017-2030)

10.1.4.2. Market Revenue and Forecast, by End-use (2017-2030)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Product (2017-2030)

10.2.2. Market Revenue and Forecast, by End-use (2017-2030)

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Product (2017-2030)

10.2.3.2. Market Revenue and Forecast, by End-use (2017-2030)

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Product (2017-2030)

10.2.4.2. Market Revenue and Forecast, by End-use (2017-2030)

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Product (2017-2030)

10.2.5.2. Market Revenue and Forecast, by End-use (2017-2030)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

10.2.6.2. Market Revenue and Forecast, by End-use (2017-2030)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Product (2017-2030)

10.3.2. Market Revenue and Forecast, by End-use (2017-2030)

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Product (2017-2030)

10.3.3.2. Market Revenue and Forecast, by End-use (2017-2030)

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Product (2017-2030)

10.3.4.2. Market Revenue and Forecast, by End-use (2017-2030)

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Product (2017-2030)

10.3.5.2. Market Revenue and Forecast, by End-use (2017-2030)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

10.3.6.2. Market Revenue and Forecast, by End-use (2017-2030)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Product (2017-2030)

10.4.2. Market Revenue and Forecast, by End-use (2017-2030)

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Product (2017-2030)

10.4.3.2. Market Revenue and Forecast, by End-use (2017-2030)

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Product (2017-2030)

10.4.4.2. Market Revenue and Forecast, by End-use (2017-2030)

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Product (2017-2030)

10.4.5.2. Market Revenue and Forecast, by End-use (2017-2030)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

10.4.6.2. Market Revenue and Forecast, by End-use (2017-2030)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Product (2017-2030)

10.5.2. Market Revenue and Forecast, by End-use (2017-2030)

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Product (2017-2030)

10.5.3.2. Market Revenue and Forecast, by End-use (2017-2030)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Product (2017-2030)

10.5.4.2. Market Revenue and Forecast, by End-use (2017-2030)

Chapter 11. Company Profiles

11.1. Danaher

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. BD

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Qiagen

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Abbott

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Siemens Healthcare AG

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. bioMerieux SA

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Zoetis, Inc.

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Instrumentation Laboratory

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Nova Biomedical

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Quidel Corp.

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Report Detail

Proceed To Buy

USD 3500
USD 7000